Insights & Discussion
Discover Related Insights
Fruits, especially kiwifruits, and rye bread can enhance bowel movements and help manage chronic constipation better than conventional dietary methods.
2023 Alimentary Pharmacology & Therapeutics Systematic review and meta‐analysis: Foods, drinks and diets and their effect on chronic constipation in adults Van Der Schoot A, Katsirma Z, Whelan K, Dimidi E
Review Article Constipation Fruits Kiwifruit
An exhaustive analysis was conducted incorporating a multitude of studies, including randomized controlled trials and uncontrolled trials, identified through electronic databases till 12th July 2023. The effect of various foods, drinks, and diets on characteristics such as stool output, gut transit time, symptoms, quality of life, adverse events, and compliance in adults with chronic constipation was inspected. The study also examined the response to different treatments and included a variety of foods such as kiwifruit, high-mineral water, prunes, rye bread, mango, fig, cereal, oat bran, yoghurt, water supplementation, prune juice, and high-fibre or no-fibre diets.
The synthesized data revealed that the consumption of fruits, particularly kiwifruits, and rye bread led to a higher stool frequency when compared to standard treatments like psyllium or white bread. High-mineral water also proved more effective regarding response to treatment than low-mineral water. On the other hand, no distinctive difference was identified for prunes when set against psyllium as a treatment option. Overall, the study insightfully suggests dietary modifications as a means to manage chronic constipation, emphasizing the potential of fruits such as kiwifruits and rye bread.
Kiwifruit and kiwifruit extracts may have a positive impact on constipation in adults by increasing weekly bowel movements, reducing abdominal pain, and minimizing straining.
2022 Canadian Journal of Gastroenterology and Hepatology Kiwifruit and Kiwifruit Extracts for Treatment of Constipation: A Systematic Review and Meta-Analysis Eltorki M, Leong R, Ratcliffe EM
Systematic Review Constipation Kiwifruit
Kiwifruit and kiwifruit extracts show promise in increasing weekly bowel movements and reducing abdominal pain and straining in adults with constipation, although the overall evidence is of low certainty. However, kiwifruit may lead to minor adverse effects, such as bloating and flatulence, compared to placebo, indicating potential for its use as a dietary supplement in constipation management, especially in conjunction with other laxatives if necessary, but further research is needed to establish its effectiveness.
Consuming green kiwifruits is associated with a clinically relevant increase of ≥ 1.5 complete spontaneous bowel movements per week in those experiencing constipation.
2022 American Journal of Gastroenterology Consumption of 2 Green Kiwifruits Daily Improves Constipation and Abdominal Comfort—Results of an International Multicenter Randomized Controlled Trial Gearry R, Fukudo S, Barbara G, Kuhn-Sherlock B, Ansell J, Blatchford P, et al.
Randomised Controlled Trial Constipation Irritable Bowel Syndrome Kiwifruit
Participants included healthy controls (n = 63), patients with functional constipation (FC, n = 60), and patients with constipation-predominant irritable bowel syndrome (IBS-C, n = 61) randomly assigned to consume 2 green kiwifruits or psyllium (7.5 g) per day for 4 weeks, followed by a 4-week washout, and then the other treatment for 4 weeks. The primary outcome was the number of complete spontaneous bowel movements (CSBM) per week. Secondary outcomes included GI comfort which was measured using the GI symptom rating scale, a validated instrument. Data (intent-to-treat) were analyzed as difference from baseline using repeated measures analysis of variance suitable for AB/BA crossover design.
Consumption of green kiwifruit was associated with a clinically relevant increase of ≥ 1.5 CSBM per week (FC; 1.53, P < 0.0001, IBS-C; 1.73, P = 0.0003) and significantly improved measures of GI comfort (GI symptom rating scale total score) in constipated participants (FC, P < 0.0001; IBS-C, P < 0.0001). No significant adverse events were observed.
Two gold kiwifruit daily are as effective as fiber-matched psyllium in treating constipation in adults and should be considered as a treatment option.
2022 Nutrients Two Gold Kiwifruit Daily for Effective Treatment of Constipation in Adults—A Randomized Clinical Trial Bayer SB, Heenan P, Frampton C, Wall CL, Drummond LN, Roy NC, et al.
Randomised Controlled Trial Constipation Kiwifruit
This study provided evidence that habitual consumption of two gold kiwifruit daily, a realistic standard serving of fruit, is at least as effective as fiber-matched psyllium in lieu of placebo in treating constipation in adults, with fewer side effects, and offers greater ease of defecation through the improvement of stool consistency and reduction of straining.
Xiao Yao San can improve symptoms and reduce recurrence rates in patients with disorders of gut-brain interaction.
2022 Frontiers in Pharmacology Efficacy and Safety of Chinese Herbal Medicine Xiao Yao San in Functional Gastrointestinal Disorders: A meta-Analysis and Trial Sequential Analysis of Randomized Controlled Trials Liu Q, Shi Z, Zhang T, Jiang T, Luo X, Su X, et al.
Systematic Review Constipation Functional gastrointestinal disorders Indigestion
The paper's methodology involved a meta-analysis of randomized controlled trials found in seven databases, up until November 22, 2021. The trials, which totaled 48 all together, were included to determine the efficacy of Xiao-Yao-San in treating disorders of gut-brain interaction (previously known as functional gastrointestinal disorders). A range of measures, including therapeutic efficacy, symptom score, Self-Rating Anxiety Scale score, Self-Rating Depression Scale score, and the recurrence rate, were analysed using both random-effects and fixed-effects models, as well as trial sequential analysis.
In terms of results, Xiao-Yao-San showed a marked improvement in the effective rate of managing disorders of gut-brain interaction compared to western drugs, both when used alone and in combination with western medicine. The paper also found the treatment notably reduced symptom scores, anxiety scores, and depression scores for patients with the disorder. Further, instances of recurrence were also reduced. Overall, Xiao-Yao-San was well tolerated and no serious adverse events were reported in any of the trials included in this analysis.
Sign In
Users not signed in are limited to viewing the 5 most recent items of content.